COMMUNIQUÉS West-GlobeNewswire

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
11/06/2026
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demonstrate a favorable [...]
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders
11/06/2026
Findings from 13 different studies analyzing 730 subjects to date in 2026 across multiple geographies underscore utility of OGM in key research areas including infertility, recurrent pregnancy loss, preimplantation [...]
KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare
11/06/2026
RIYADH, Saudi Arabia, June 11, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its participation at HLTH [...]
Arizona Nonprofit Launches “America 250” Fundraiser Featuring 250 Winners to Support Childhood Blindness Research
11/06/2026
A Race Against Blindness celebrates America’s 250th anniversary with a major fundraising campaign featuring vehicles, cash prizes, and a life-changing impact for children facing blindness GILBERT, Ariz., June 11, 2026 ( [...]
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
11/06/2026
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply [...]
RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic Cancer
11/06/2026
PET-CT imaging, Rather than CT Alone, Presented a Meaningful Reduction in Tumor Metabolic Activity After Treatment, Suggesting that PET May Help to Optimize Therapeutic Response Monitoring Following Treatment Delivered [...]
Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
11/06/2026
Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, is pleased to announce that [...]
Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
11/06/2026
– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007 trial – – 96% CRc in newly diagnosed NPM1-m AML; 90% CRc in newly diagnosed KMT2A-r AML – – High rates of MRD [...]
Announcing the 2026 Hall of Fame Philadelphia Titan 100 Honorees
11/06/2026
BERWYN, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- Titan CEO and headline sponsor Cherry Bekaert are pleased to announce Dea Belazi, CEO and co-founder, AscellaHealth , a global partner delivering customizable solutions for [...]
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
11/06/2026
- Following the pre-specified interim safety report and overwhelming demand from clinicians to treat patients as quickly as possible, Alpha Tau to resume recruitment immediately for the remaining seven patients in the [...]
BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events
11/06/2026
Idan Wasserman contends that major global events require AI systems that can understand context, reduce false alarms, and identify relevant security alerts NETANYA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. ( [...]
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
11/06/2026
The clearance combines OraSure’s Colli-Pee™•Dx Urine Collection Kit for at-home sample collection with Roche’s cobas® molecular lab testing equipment BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure [...]
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
11/06/2026
PMA supplement under FDA review with potential approval in H2 2026, potentially expanding the Company’s addressable market to include TCAR in addition to CAS carotid stenting procedures MIAMI, June 11, 2026 (GLOBE [...]
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
11/06/2026
Presentations, panels and moderated discussions across the four-day conference will span proven AI applications across the clinical trial lifecycle, real world evidence, risk-based quality management and patient- [...]
Loma Linda University Health and Nudj Health Launch Integrated Whole-Person Primary Care Model Designed to Advance the Future of Healthcare Delivery
11/06/2026
Academic Medical Center Integrates Lifestyle Medicine, Behavioral Health, and Longitudinal Care Tech-Enabled Services into Primary Care Workflows with Research Initiative Focused on Medicare Sustainability and Chronic [...]
Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy
11/06/2026
High objective response rate of 92.9% in second line patients who have progressed on a BTK inhibitor and have not received BCL2 inhibitor treatment Updated Phase 1a data further supports a median progression-free [...]
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management
11/06/2026
Declining estrogen during perimenopause accelerates visceral fat accumulation and lean muscle loss, two outcomes that standard weight management programs are not designed to address together (Szeliga A, et al., 2026) [...]
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
11/06/2026
– Real-world study of revumenib shows 82% (9/11) ORR and 64% (7/11) CR/CRh rate among R/R NPM1m or KMT2Ar patients treated with revumenib monotherapy or combinations – – Ph 1 trial of revumenib with intensive [...]
Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
11/06/2026
Cebranopadol is an investigational, first-in-class dual-NMR agonist in development for acute and chronic pain as well as opioid use disorder Five scientific presentations will feature preclinical and clinical data [...]

Pages